GoldCorp Analysts

Within all the problems facing the U.S. economy such as fiscal deficit, the loss of power of the dollar, among others. GoldCorp Analysts believe a strong balance sheet combined with the ability to capitalize on hard times. The company was investigating “Penasquitos Mine” in the Mexican country in order to continue expanding. He also initiated the construction of a new mine in the city of Ontario in Canada about its other gold mines. This is a great investment opportunity to generate large revenues. GoldCorp has one of the lowest production costs in the mining industry with a strong balance sheet allows you to have an acceptable dividend policy.

Buy a mine is much more risky than buying gold mining stocks because they can fall defeated when construction projects are delayed a bit and also an increase in the share price could have a big impact on profit margins of the mines. But today or invest in gold mines is an attractive opportunity to keep us safe from the comings and goings of the economy. Coca-Cola (KO) Coca-Cola has it all really. Attractive dividend policies, expanded global business and a very affordable price per share. CocCola generated profits beyond all the trouble is with the American currency and commodity prices.

The company has the ability to generate large amounts of cash that allow it to grow and develop in any economic field. Muthar Coke CEO Kent said the idea of them is to invest more than $ 2 billion in China over the next three years. Procter & Gamble (PG) With a possible recession or not, Proceter & Gamble plans to invest one trillion dollars in new customers over the next five years. The popular-based firm Cincinnati went through several turbulence last year by the large number of private labels competing for total sales. A cheap dollar and the sale of its branch pharmacist will generate $ 3 billion in cash, giving you some protection as they lower prices for encouraging the “shoopers.” CEO Robert McDonald said P & G is investing heavily in new products and brand extensions such as oils Olay brand in Asia. Abbott Laboratories (ABT) Equity medical settings are surrounded by a lot of questions. The largest pharmaceutical are having trouble following patents protecting its most important drug. While other earnings may be shortened by reimbursement in medicine. Abbott is taking advantage of good earnings and has been making interesting acquisitions. The largest was the disbursement of U.S. $ 6 billion to acquire the pharmaceutical sector in Belguim’s Solvey what Abbot term to transform a major player in the world of vaccines. The action is quoted three times more than analysts expected earnings for the 2010 and 3% of dividends.

Monday, October 18th, 2010 News